TCL Archive Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable April 26, 2013
TCL Archive In Brief: ACS to Spend Record $85 Million On Research: AACR To Honor Hanafusa, DeVita, Barbacid March 14, 1986